Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation

Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation

Hideki Ishida, Kazunari TanabeDepartment of Urology, Tokyo Women&rsquo;s Medical University, Tokyo, JapanAbstract: A patient showing antibody-mediated rejection (AMR) with severe vasculitis, and massive proteinuria after kidney transplantation was treated with deoxyspergualine (DSG, Spanidin...

Full description

Bibliographic Details
Main Authors:	Hideki Ishida, Kazunari Tanabe
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-06-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/efficacy-of-deoxyspergualine-for-antibody-mediated-rejection-and-prote-a1889

Similar Items

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.
by: Flossmann, O, et al.
Published: (2009)

Treatment of Antibody-Mediated Rejection in Kidney Transplantation
by: Magdalena Durlik
Published: (2013-07-01)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
by: Farah Abuazzam, et al.
Published: (2023-07-01)

Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
by: Davide Spica, et al.
Published: (2019-11-01)

The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
by: Aleksandar Senev, et al.
Published: (2022-02-01)

Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory Wegener's granulomatosis
by: Flossmann, O, et al.
Published: (2007)

Acute antibody-mediated rejection after pancreas transplantation
by: Érika Bevilaqua Rangel, et al.
Published: (2008-09-01)

Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection after Renal Transplantation.
by: Takeshi Maehana, et al.
Published: (2016-01-01)

Influence of Persistent Inflammation in Follow-Up Biopsies After Antibody-Mediated Rejection in Kidney Transplantation
by: Gaston J. Piñeiro, et al.
Published: (2021-11-01)

Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01)

Current perspectives on antibody-mediated rejection after lung transplantation
by: Witt CA, et al.
Published: (2014-10-01)

A bibliometric and knowledge-map analysis of antibody-mediated rejection in kidney transplantation
by: Jinhua Zhang, et al.
Published: (2023-12-01)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
by: Lara Cabezas, et al.
Published: (2022-04-01)

An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation
by: Lisa K. Seiler, et al.
Published: (2022-01-01)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
by: Marta Crespo, et al.
Published: (2021-07-01)

Impact of preoperative proteinuria on renal functional outcomes after open partial nephrectomy in patients with a solitary kidney
by: Hidekazu Tachibana, et al.
Published: (2017-11-01)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
by: Constantino Fernández Rivera, et al.
Published: (2022-11-01)

Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody−Mediated Rejection after Kidney Transplantation
by: Mi Joung Kim, et al.
Published: (2022-09-01)

Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection
by: Wang J, et al.
Published: (2023-03-01)

Successful Salvage Treatment of Resistant Acute Antibody-Mediated Kidney Transplant Rejection with Eculizumab
by: Saif A. Khan, et al.
Published: (2016-08-01)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
by: Nicole Nourié, et al.
Published: (2022-03-01)

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients
by: Inge Mertens, et al.
Published: (2020-09-01)

Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection
by: Satoshi Miyairi, et al.
Published: (2021-07-01)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
by: Woo Yeong Park, et al.
Published: (2021-03-01)

Late acute antibody mediated rejection after nine years of renal transplantation
by: Halim Medhat, et al.
Published: (2010-01-01)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
by: Tetsuya Tajima, et al.
Published: (2023-06-01)

Acute rejection episodes after kidney transplantation
by: Hamida Fethi, et al.
Published: (2009-01-01)

Proposed definitions of antibody-mediated rejection for use as a clinical trial endpoint in kidney transplantation
by: Roufosse, C, et al.
Published: (2022)

Acute antibody-mediated rejection with graft loss during anti-tuberculosis therapy in kidney transplantation
by: Hao-Wen Chuang
Published: (2015-08-01)

POS-686 UِSE OF BORTEZOMIB IN TREATMENT OF KIDNEY TRANSPLANT SUB-CLINICAL ANTIBODY MEDIATED REJECTION
by: A. AL-OMAIRI, et al.
Published: (2021-04-01)

PSMP Is Discriminative for Chronic Active Antibody-Mediated Rejection and Associate With Intimal Arteritis in Kidney Transplantation
by: Panpan Zhan, et al.
Published: (2021-04-01)

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring
by: Johan Noble, et al.
Published: (2021-12-01)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
by: Yusuke Yanagi, MD, PhD, et al.
Published: (2022-09-01)

Ferroptosis related gene signature in T cell-mediated rejection after kidney transplantation
by: Weixun Zhang, et al.
Published: (2023-01-01)

Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection
by: Taro Banno, et al.
Published: (2024-02-01)

IL-10 and IL-4 in Skin Allograft Survival Induced by T-Cell Depletion plus Deoxyspergualin
by: Clement Asiedu, et al.
Published: (2008-06-01)

Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study
by: Dharmendra Bhadauria, et al.
Published: (2022-01-01)

Early Antibody-Mediated Kidney Transplant Rejection: A Successful Case Without Donor-Specific Anti-HLA Antibodies
by: Rita M. Silva, et al.
Published: (2023-06-01)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
by: Duangtawan Thammanichanond, et al.
Published: (2022-05-01)

Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation – from cellular rejection to antibody-mediated rejection?
by: Sylwia Szymanska, et al.
Published: (2016-11-01)